Closing Bell Roundup

The Pipeline’s Back to Tunnel in Profits

After years in limbo, a major energy asset restarts. The stock soars 36%.

This Silver Discovery Could Rewrite the Map

This Breakout Pattern Could Be the Start of Something Bigger

A breakout above key resistance is drawing fresh eyes as this stock surges 77%.

This Biotech’s Latest Acquisition Could Change the Game in Breast Cancer

Phase 3 data incoming after oncology licensing sparks big momentum and investor interest.

The Cancer Trial Healing Portfolio Pains

With Delisting Fears Gone, This Stock Is Back in the Game

Delisting fears fade after a surprise Q2 profit, causing this stock to jump 53%.